Company Overview of Zirus, Inc.
Zirus, Inc. provides a platform of host targets and a process for finding additional targets and drugs to treat commercially relevant, pandemic, neglected disease, or bioterrorist-designed viruses. The company offers Zirus Gene Trap, an antiviral host target discovery platform for the discovery of human host gene targets essential for viral replication, as well as drugs to block viral infection. Its platform is used for the development of antiviral products, drugs, and therapies. The company was incorporated in 2007 and is based in Buford, Georgia.
1384 Buford Business Boulevard
Buford, GA 30518
Founded in 2007
Key Executives for Zirus, Inc.
Similar Private Companies By Industry
|OyaGen, Inc.||United States|
|Altheos, Inc.||United States|
|Transplant Genomics, Inc.||United States|
|Mosaic Biosciences, Inc.||United States|
|PeptiVir, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- St Louis, MO | Nova BiomedicalPosted: Apr 07
- Gaithersburg, MD | MedimmunePosted: Apr 16
- San Mateo, CA |Posted: Apr 05
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
Sponsored Financial Commentaries
To contact Zirus, Inc., please visit www.zirus.net. Company data is provided by Capital IQ. Please use this form to report any data issues.